Consolidated Statements of Cash Flows - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating Activities
Net income before allocation to noncontrolling interests		$ 31,407	$ 22,025	$ 9,195
Discontinued operations––net of tax		6	(434)	2,529
Net income from continuing operations before allocation to noncontrolling interests		31,401	22,459	6,666
Adjustments to reconcile net income before allocation to noncontrolling interests to net cash provided by operating activities:
Depreciation and amortization		5,064	5,191	4,681
Asset write-offs and impairments		550	276	2,049
Deferred taxes from continuing operations		(3,764)	(4,293)	(1,575)
Share-based compensation expense		872	1,182	755
Benefit plan contributions in excess of expense/income		(1,158)	(3,123)	(1,242)
Other adjustments, net		758	(1,573)	(485)
Other changes in assets and liabilities, net of acquisitions and divestitures:
Trade accounts receivable		261	(3,811)	(1,275)
Inventories		592	(1,125)	(778)
Other assets	[1]	(4,506)	(1,057)	(137)
Trade accounts payable		1,191	1,242	355
Other liabilities		(1,449)	18,721	2,768
Other tax accounts, net		(545)	(1,166)	(1,240)
Net cash provided by operating activities from continuing operations		29,267	32,922	10,540
Net cash provided by/(used in) operating activities from discontinued operations		0	(343)	3,863
Net cash provided by operating activities		29,267	32,580	14,403
Investing Activities
Purchases of property, plant and equipment		(3,236)	(2,711)	(2,226)
Purchases of short-term investments		(36,384)	(38,457)	(13,805)
Proceeds from redemptions/sales of short-term investments		44,821	27,447	11,087
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less		(483)	(8,088)	920
Purchases of long-term investments		(1,913)	(1,068)	(597)
Proceeds from redemptions/sales of long-term investments		641	649	723
Acquisitions of businesses, net of cash acquired		(22,997)	0	0
Dividend received from the Consumer Healthcare JV	[2]	3,960	0	0
Other investing activities, net		(192)	(305)	(265)
Net cash provided by/(used in) investing activities from continuing operations		(15,783)	(22,534)	(4,162)
Net cash provided by/(used in) investing activities from discontinued operations		0	(12)	(109)
Net cash provided by/(used in) investing activities		(15,783)	(22,546)	(4,271)
Financing Activities
Proceeds from short-term borrowings		3,891	0	12,352
Payments on short-term borrowings		(3,887)	0	(22,197)
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less		(222)	(96)	(4,129)
Proceeds from issuances of long-term debt		0	997	5,222
Payments on long-term debt		(3,298)	(2,004)	(4,003)
Purchases of common stock		(2,000)	0	0
Cash dividends paid		(8,983)	(8,729)	(8,440)
Other financing activities, net		(335)	16	(444)
Net cash provided by/(used in) financing activities from continuing operations		(14,834)	(9,816)	(21,640)
Net cash provided by/(used in) financing activities from discontinued operations		0	0	11,991
Net cash provided by/(used in) financing activities		(14,834)	(9,816)	(9,649)
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents		(165)	(59)	(8)
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents		(1,515)	159	475
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period		1,983	1,825	1,350
Cash and cash equivalents and restricted cash and cash equivalents, at end of period		468	1,983	1,825
Cash paid/(received) during the period for:
Income taxes		7,867	7,427	3,153
Interest paid		1,442	1,467	1,641
Interest rate hedges		54	(2)	(20)
Non-cash transaction:
Right-of-use assets obtained in exchange for lease liabilities		$ 752	$ 1,943	$ 410

[1] See Note 8A.

[2] See Note 2C.